Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 6826 AL 6840

Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer's Disease and Parkinson's Dementia: Systematic Review and Meta-Analysis

Bittner N, Funk CSM, Schmidt A, Bermpohl F, Brandl EJ, Algharably EEA, Kreutz R, Riemer TG.

Drugs Aging. 2023 Nov;40(11):953-964. doi: 10.1007/s40266-023-01065-x. Epub 2023 Sep 8.

Buntanetap, a Novel Translational Inhibitor of Multiple Neurotoxic Proteins, Proves to Be Safe and Promising in Both Alzheimer's and Parkinson's Patients

Fang C, Hernandez P, Liow K, Damiano E, Zetterberg H, Blennow K, Feng D, Chen M, Maccecchini M.

J Prev Alzheimers Dis. 2023;10(1):25-33. doi: 10.14283/jpad.2022.84.

Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients' data analysis

Corniello C, Dono F, Evangelista G, Consoli S, De Angelis S, Cipollone S, Liviello D, Polito G, Melchiorre S, Russo M, Granzotto A, Anzellotti F, Onofrj M, Thomas A, Sensi SL.

Seizure. 2023 Jul;109:62-67. doi: 10.1016/j.seizure.2023.05.017. Epub 2023 May 21.

[Abnormal posture of the trunk related to donepezil hydrochloride: report of 2 cases]

Ueda A, Komatsu K, Takahashi M.

Rinsho Shinkeigaku. 2023 Feb 25;63(2):85-91. doi: 10.5692/clinicalneurol.cn-001792. Epub 2023 Jan 31.

Protocol of a randomized controlled trial investigating Deep Brain Stimulation for MOtor symptoms in patients with Parkinson's disease DEmentia (DBS-MODE)

Sisodia V, Swinnen BEKS, Dijk JM, Verwijk E, van Rooijen G, Lemstra AW, Schuurman PR, de Bie RMA.

BMC Neurol. 2023 Apr 21;23(1):160. doi: 10.1186/s12883-023-03142-5.

Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders

Birajdar SV, Mazahir F, Alam MI, Kumar A, Yadav AK.

Eur J Pharmacol. 2023 Dec 15;961:176117. doi: 10.1016/j.ejphar.2023.176117. Epub 2023 Oct 30.

Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases

Lizama BN, Kahle J, Catalano SM, Caggiano AO, Grundman M, Hamby ME.

Int J Mol Sci. 2023 Mar 26;24(7):6251. doi: 10.3390/ijms24076251.

The Regulation, Functions, and Signaling of miR-153 in Neurological Disorders, and Its Potential as a Biomarker and Therapeutic Target

Jaberi KR, Alamdari-Palangi V, Jaberi AR, Esmaeli Z, Shakeri A, Gheibi Hayat SM, Tajbakhsh A, Savardashtaki A.

Curr Mol Med. 2023;23(9):863-875. doi: 10.2174/1566524023666220817145638.

Neurobiochemical characteristics of arginine-rich peptides explain their potential therapeutic efficacy in neurodegenerative diseases

Eskandari S, Rezayof A, Asghari SM, Hashemizadeh S.

Neuropeptides. 2023 Oct;101:102356. doi: 10.1016/j.npep.2023.102356. Epub 2023 Jun 23.

Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy

Voicu V, Brehar FM, Toader C, Covache-Busuioc RA, Corlatescu AD, Bordeianu A, Costin HP, Bratu BG, Glavan LA, Ciurea AV.

Biomolecules. 2023 Sep 14;13(9):1388. doi: 10.3390/biom13091388.

Molecular mechanisms of neuroprotective offerings by rosmarinic acid against neurodegenerative and other CNS pathologies

Ravaria P, Saxena P, Laksmi Bs S, Ranjan V, Abidi SWF, Saha P, Ramamoorthy S, Ahmad F, Rana SS.

Phytother Res. 2023 May;37(5):2119-2143. doi: 10.1002/ptr.7825. Epub 2023 Apr 4.

The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms

Alavi MS, Karimi G, Ghanimi HA, Roohbakhsh A.

Eur J Pharmacol. 2023 Jun 15;949:175726. doi: 10.1016/j.ejphar.2023.175726. Epub 2023 Apr 14.

Therapeutic implications of phosphorylation- and dephosphorylation-dependent factors of cAMP-response element-binding protein (CREB) in neurodegeneration

Khakha N, Khan H, Kaur A, Singh TG.

Pharmacol Rep. 2023 Oct;75(5):1152-1165. doi: 10.1007/s43440-023-00526-9. Epub 2023 Sep 9.

Targeting mitophagy for neurological disorders treatment: advances in drugs and non-drug approaches

Yang X, Zhang Y, Luo JX, Zhu T, Ran Z, Mu BR, Lu MH.

Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec;396(12):3503-3528. doi: 10.1007/s00210-023-02636-w. Epub 2023 Aug 3.

Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine

Jin S, Zhang L, Wang L.

Biomed Pharmacother. 2023 Sep;165:115215. doi: 10.1016/j.biopha.2023.115215. Epub 2023 Jul 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias